JMDC Inc
TSE:4483

Watchlist Manager
JMDC Inc Logo
JMDC Inc
TSE:4483
Watchlist
Price: 3 864 JPY -1.1% Market Closed
Market Cap: 252.6B JPY
Have any thoughts about
JMDC Inc?
Write Note

Net Margin
JMDC Inc

10.9%
Current
15%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
10.9%
=
Net Income
4.1B
/
Revenue
37.8B

Net Margin Across Competitors

Country JP
Market Cap 252.5B JPY
Net Margin
11%
Country US
Market Cap 35.3B USD
Net Margin
25%
Country US
Market Cap 31.3B USD
Net Margin
10%
Country AU
Market Cap 26.1B AUD
Net Margin
50%
Country US
Market Cap 10.9B USD
Net Margin
34%
Country US
Market Cap 6.5B USD
Net Margin
-6%
Country JP
Market Cap 927.9B JPY
Net Margin
16%
Country US
Market Cap 5.6B USD
Net Margin
4%
Country SE
Market Cap 53.2B SEK
Net Margin
25%
Country US
Market Cap 2.4B EUR
Net Margin
-4%
Country CN
Market Cap 15.9B CNY
Net Margin
11%
No Stocks Found

JMDC Inc
Glance View

Market Cap
252.5B JPY
Industry
Health Care

Amidst the complex intersection of healthcare and technology, JMDC Inc. has carved a unique niche by harnessing the power of big data to improve healthcare outcomes and efficiency. Founded in Japan, the company stands as a beacon in the health informatics sector, meticulously collecting and analyzing health-related data drawn from a variety of sources, including medical claims, health screenings, and electronic health records. By transforming this extensive data trove into actionable insights, JMDC offers healthcare providers, pharmaceutical companies, and insurance firms the analytics they need to make informed decisions. Key to JMDC's operation is its commitment to safeguarding patient anonymity while extracting valuable insights that can streamline healthcare delivery, enhance pharmaceutical research, and optimize insurance underwriting. JMDC's revenue model hinges on the sale of its aggregated data and analytics solutions to a vast array of stakeholders in the medical field. Pharmaceutical companies, eager to understand drug efficacy and patient demographics better, turn to JMDC for data-driven insights that can influence drug development and marketing strategies. Insurance companies leverage JMDC's data to refine their offerings and better assess risk, ensuring competitive pricing models and improved customer satisfaction. Moreover, healthcare providers utilize this analytics backbone to enhance operational efficiency and improve patient care outcomes. Through licensing agreements and subscription-based services, JMDC effectively monetizes its data resources, achieving sustained growth in an industry that increasingly values the marriage of technology and healthcare.

Intrinsic Value
3 587.97 JPY
Overvaluation 7%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
10.9%
=
Net Income
4.1B
/
Revenue
37.8B
What is the Net Margin of JMDC Inc?

Based on JMDC Inc's most recent financial statements, the company has Net Margin of 10.9%.